#Canada #Calgary #Nanalysis #Security Services #NMR Spectrometers

Nanalysis Scientific Corp. Reports First Quarter Financial Results for 2026

CALGARY, AB, May 20, 2026 - Nanalysis Scientific Corp. (TSXV: NSCI, FRA: 1N1), renowned for its innovative portable Nuclear Magnetic Resonance (NMR) spectrometers and MRI technology, shared its financial results for the first quarter of 2026, ending March 31. The company’s growth trajectory continues amidst a challenging market landscape.

Key Financial Metrics

Nanalysis recorded total revenue of $10.7 million for the first quarter of 2026, which is a stable figure compared to both the previous quarter and the same period in 2025. Significant operational progress was evident with an Adjusted EBITDA of $292,000, reflecting a rise of $112,000 from the prior year’s quarter. According to Sean Krakiwsky, CEO, this consistent revenue performance demonstrates the company’s resilience despite longer sales cycles in certain markets for scientific equipment.

The revenue structure showed a clear segmentation:

• - Product Sales: Contributed $2.2 million, experiencing a decline of 41% year-over-year due to reduced NMR benchtop sales and the discontinuation of third-party equipment sales contracts.
• - Security Services Revenue: Grew by 18% to $5.9 million, driven by heightened project-related efforts in the Airport Security Maintenance sector.
• - Flow-through Inventory Revenue: Increased significantly by 37% to $2.6 million, marking a strategic uptick in this area as well.

Operational Highlights

The company’s gross margin demonstrated an interesting divide:

• - For product sales, the gross margin percentage fell to 58%, down from 66%, primarily due to changes in product mix.
• - Conversely, gross margin for security services showed marked improvement, rising to 19% from just 6% in the prior year, underscoring successful operational enhancements.

This positive margin shift in the security services sector is attributed to effective management of operational costs and project-related efficiencies. These operational improvements are critical as they position Nanalysis to maintain a steady financial performance, further solidifying its place in the industry.

Future Strategies and Outlook

Management has reiterated its commitment to driving improved operational execution throughout 2026. This commitment is supported by the recent expansion of the company’s sales and marketing team in Europe and strengthened international distributor relationships, particularly beneficial for their benchtop NMR sales. With investments leading to more robust sales cycle engagements, Nanalysis aims for enhanced sales activity moving forward.

Nanalysis is keenly aware of macroeconomic challenges affecting purchasing decisions in the scientific equipment sector but remains committed to disciplined execution and fostering long-term value for its stakeholders.

Conclusion

In light of the recent financial performance, Nanalysis Scientific Corp. continues to show robust capabilities in navigating a competitive landscape. The combination of strategic planning, operational efficiencies, and a focus on service-driven revenue streams positions the company favorably for the upcoming quarters. As the company gears up for its upcoming conference call on May 21, 2026, interest is likely to rise as investors and stakeholders seek insights into the ongoing progress and future direction.

For more information or to join the conference call, please visit the Nanalysis investor relations page at [Company's Website].